Aida Pharmaceuticals (AIDA)

[canric]

The 7M loss is true loss, it may take years to get some recovery, not very helpful. But I view it as one time hit(26 cents/share). Now price down 50+ cents.

The current business worths .70, even more, considering the growth.

The cancer drug will make aida a 10 bagger if it got approved, which has big chance.

The liquidity is a big issue. But considering this company has strong gov support, 70 cent entry gives us good reward/risk ratio.